Objective: This study assessed variation between neurologists in the U
nited States and United Kingdom in their diagnostic and treatment deci
sions for commonly encountered neurologic presentations, and identifie
d explanatory factors for any observed variation. Methods: All 210 con
sultant neurologists in the United Kingdom and a nationally representa
tive sample of 595 US neurologists received mailed surveys containing
three detailed clinical scenarios depicting patients with (1) a single
unprovoked seizure occurring 3 days previously, (2) early Parkinson's
disease, and (3) dementia. The main study outcome measures were self-
reported decisions regarding diagnostic test ordering and treatment, w
hich were assessed after each scenario. Neurologists' practice charact
eristics, certainty about the diagnosis, and attitudes toward uncertai
nty were also measured. Survey response rates were 92% of US and 63% o
f UK neurologists, Results: A higher proportion of US than UK neurolog
ists indicated they would order additional diagnostic tests for all th
ree scenarios (all p < 0.05); 77% of UK compared with 26% of US neurol
ogists would manage a single unprovoked seizure without antiepileptic
medication (p < 0.0001), but treatment of early Parkinson's disease wa
s not different. Nearly all US and UK neurologists would obtain a neur
oimaging study in the evaluation of dementia. International difference
s persisted after adjustment for differences in demographic and practi
ce characteristics and for attitudes toward test use and clinical unce
rtainty. Conclusions: We identified large international variation in c
linical decisions across three common neurologic conditions, Cross-cou
ntry collaboration should explore these differences to develop consens
us on standards of care.